This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
MTOR signaling pathway
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='' scene='90/908701/Rapamycin/1'> | <StructureSection load='' size='340' side='right' caption='' scene='90/908701/Rapamycin/1'> | ||
| - | + | '''mTOR''' (mammalian target of [[Rapamycin]]) integrates the input from insulin, growth factors and amino acids. [[Rapamycin]] inhibits mTOR by association with FKBP12<ref>PMID:22500797</ref>. | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 10:50, 5 April 2022
| |||||||||||
References
- ↑ Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012 Apr 13;149(2):274-93. doi: 10.1016/j.cell.2012.03.017. PMID:22500797 doi:http://dx.doi.org/10.1016/j.cell.2012.03.017
